NCT04818034View on ClinicalTrials.gov

The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

December 13, 2021

Study Completion Date

April 28, 2022

Conditions
Cystinuria
Interventions
DRUG

Dapagliflozin

Dapagliflozin is to lower blood sugar levels in adults with type 2 diabetes.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04818034 - The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study | Biotech Hunter | Biotech Hunter